Skip to main content

Diabetes Drug News

Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.

Metformin     Insulin     SGLT-2     GLP-1     DPP-4     Combo drugs     Sulfonylureas     TZDs

Learn how you can get affordable insulin without insurance coverage
As we continue to navigate the COVID-19 pandemic through the fall and winter, it is especially important for you to get both your seasonal flu shot and new bivalent...
Nobody with diabetes should have to put their health and safety at risk because they can’t afford insulin. US National Health Survey data shows that many people have to...
Based on recently published clinical trial data, an ultra rapid-acting mealtime insulin was just approved for use in children with diabetes, expanding the mealtime...
Diet and exercise are often insufficient for people with obesity, leading many to pursue alternatives. The American Gastroenterological Association published guidelines...
Lyumjev reduces blood glucose spikes and can be taken at the beginning of a meal, or even 20 minutes into the meal; available through Lilly’s insulin affordability...
New drugs have been developed to help people with type 2 diabetes lose weight, lower glucose, and prevent complications. These options have not been approved to treat...
Mounjaro, a drug approved in 2022 to treat type 2 diabetes, has also shown remarkable weight-loss effects, reducing trial participants’ weight by over 20%. Regulators...
About 200 million people with diabetes around the world require daily insulin. Once-weekly basal insulins, if approved, could require fewer injections and potentially...
Adding 20 new factors, a whole new category on behavior and decisions, and research on unexpected things that impact blood sugar and diabetes
Preventing type 1 diabetes – the main goal for some who do not believe a cure is possible – would ultimately bring this ancient disease to its end. The world’s top...
A fascinating session at the EASD 2022 conference on emerging technologies sheds light on where we are with AID and telemedicine, and what leading researchers in...
Public speaking professor Alan Uphold shares his experiences with severe low blood sugars and explains why it’s so important to communicate with your loved ones and care...
An actively recruiting clinical trial is seeking to evaluate a new drug to treat diabetic kidney disease (DKD). This new injectable drug will be given alongside Farxiga...
Impressive results from the DELIVER trial show that dapagliflozin (Farxiga), a SGLT-2 inhibitor, could be used to treat all types of heart failure, a common diabetes...
Encouraging trial results from Novo Nordisk show that a new combination therapy in development could help people lower their A1C and weight dramatically. With the...
Approximately 17% of people with diabetes have diabetic cardiomyopathy, a dangerous complication that can lead to heart failure. This clinical trial is focused on...
The recently passed Inflation Reduction Act includes new policies that cap the monthly cost of insulin at $35 and potentially reduce the cost of other diabetes drugs for...
The ready-to-use autoinjector emergency glucagon pen is now available for people over the age of two in the US
Insulet recently announced that the Omnipod 5 automated insulin delivery (AID) system is now fully available to anyone with type 1 diabetes ages 2 and up. Read about...

Pages